Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for mumps immunity with the microtiter solid-phase radioimmunoassay

R Hernandez, M Just, A Bürgin-Wolff

    Infection
    |January 1, 1976
    PubMed
    Summary

    A new solid phase radioimmunoassay effectively detects mumps antibodies in human sera. This sensitive method is ideal for large-scale screening in vaccination programs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

    ESMO open·2026
    Same author

    Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N = 7914).

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same author

    Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

    ESMO open·2025
    Same author

    Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry.

    ESMO open·2025
    Same author

    Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).

    ESMO open·2025
    Same author

    Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025

    Area of Science:

    • Immunology
    • Virology
    • Diagnostic Assays

    Background:

    • Mumps virus infections require reliable antibody detection methods for epidemiological surveillance and vaccine efficacy assessment.
    • Existing serological tests like hemagglutination inhibition (HI) and virus neutralization (VN) have limitations in sensitivity or throughput.
    • Development of sensitive and efficient assays is crucial for monitoring mumps immunity in populations.

    Purpose of the Study:

    • To adapt and validate a solid phase radioimmunoassay (SPRIA) for the quantitative estimation of mumps antibodies.
    • To evaluate the sensitivity and utility of the adapted SPRIA compared to established serological methods.
    • To assess the suitability of the SPRIA for screening large numbers of human serum samples.

    Main Methods:

    • A solid phase radioimmunoassay was developed using microtiter plates.
    • Commercially available complement-fixing mumps antigen was utilized for antibody capture.
    • The assay involved incubating serum samples, followed by detection of bound antibodies.
    • Performance was compared against hemagglutination inhibition and virus neutralization tests.

    Main Results:

    • The developed solid phase radioimmunoassay demonstrated high sensitivity for mumps antibody detection.
    • The assay's sensitivity was found to be superior to hemagglutination inhibition.
    • Sensitivity was comparable to the gold standard virus neutralization test performed on chick fibroblasts.
    • The method proved effective for processing large series of human sera.

    Conclusions:

    • The adapted solid phase radioimmunoassay is a sensitive and reliable method for quantifying mumps antibodies.
    • This assay offers advantages for large-scale serological screening, particularly in the context of mumps vaccination programs.
    • The SPRIA provides a valuable tool for public health initiatives monitoring mumps immunity and vaccine effectiveness.

    Related Experiment Videos